Brain Tumor Therapeutics
Brain Tumor Therapeutics - Related Videos
04:48
Intracranial Cannular Implantation in a Mouse to Deliver Therapeutic Agents to Brain Tumors
0 Views •
2025
This video presents a procedure for intracranial cannula implantation in a brain tumor mouse model, to facilitate the administration of an immunotherapeutic agent. The delivery of glypican-2-specific chimeric antigen receptor T cells in the tumor microenvironment triggers T cell activation, resulting in tumor lysis and tumor regression.
07:02
Blood-Brain Tumor Barrier or BBTB Model: An Adaption of the Blood-Brain Barrier or BBB Model to Evaluate Delivery of Therapeutics to the Tumor
0 Views •
2023
In this video, we describe a comprehensive protocol to establish an in vitro model mimicking the blood-brain tumor barrier. The model holds promise to understand the delivery of therapeutic agents for the treatment of brain tumors.
12:09
A Novel High-resolution In vivo Imaging Technique to Study the Dynamic Response of Intracranial Structures to Tumor Growth and Therapeutics
0 Views •
Cited by 14 •
2013
We describe a novel in vivo imaging technique that couples fluorescent chimeric mice with intracranial windows and high-resolution 2-photon microscopy. This imaging platform aids studies of dynamic changes in brain tissue and microvasculature, at a single-cell level, following pathological insults and is adaptable to assess intracranial drug delivery and distribution.
03:45
Tumor Treating Fields Application in Human Brain Tumor Models: A Non-invasive Technique to Deliver Alternating Electric Fields to Human Brain for Treating Brain Tumor
0 Views •
2023
This video demonstrates the application of Tumor Treating Fields or TTFields in human brain tumor models. This non-invasive technique delivers low-intensity alternating electric fields directly to the brain, resulting in inhibition of cell division and subsequent apoptosis.
03:33
Intranasal Delivery of Therapeutic Neural Stem Cells (NSCs) in Murine Model: A Procedure for Tumor-targeted Delivery of Oncolytic Virus Loaded NSCs into Brain Tumor Bearing Mouse Model
0 Views •
2025
This video demonstrates the intranasal delivery of oncolytic virus loaded therapeutic neural stem cells into a brain-tumor bearing mouse model. The non-invasive intranasal administration of stem cells bypasses the blood brain barrier, facilitating their delivery to the tumor site in the brain for therapeutic applications.
FAQs
Different tumor regions or tumors with different molecular features may not respond identically to one therapy. This heterogeneity is why treatment selection considers tumor type, location, and molecular profile rather than relying on a single universal regimen. Combining approaches can address distinct therapeutic needs while helping balance tumor control against injury to healthy brain tissue.
The blood-brain barrier complicates treatment because drug-delivery systems must support access to tumors in the brain and central nervous system. This limitation makes delivery a major research focus, alongside molecular profiling and clinical trials. Improving access could help therapies reach their intended targets while supporting efforts to preserve healthy brain tissue.
Surgery can remove tumor tissue, radiation and chemotherapy can damage cancer-cell DNA, targeted drugs can inhibit growth pathways, and immunotherapy can activate immune responses. These mechanisms act through different biological routes, so treatment combinations may address more than one feature of tumor growth. Their use must still be balanced against neurological effects and harm to healthy tissue.
Treatment planning depends on the tumor type, its location, and its molecular features. These factors help determine whether surgery, radiation, chemotherapy, targeted drugs, immunotherapy, or a combination is appropriate. Considering them together supports a more precise strategy, particularly because tumors vary biologically and because treatment must account for the need to preserve neurological function.
Evaluation extends beyond whether tumor tissue is controlled or eliminated. Important goals include extending survival, preserving neurological function, reducing recurrence, and limiting harm to healthy brain tissue. These outcomes reflect the difficult balance in cancer research between effective tumor control and the protection of the surrounding central nervous system.
Molecular profiling can provide information used to develop more precise treatment strategies, while drug-delivery systems address challenges created by the brain environment. Clinical trials test emerging approaches and help investigate whether these innovations improve therapeutic effectiveness or reduce unwanted effects. Together, these research directions support continued development of more targeted Brain Tumor Therapeutics.